Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NOVN save search
Novan to Participate in the Virtual Investor Innovation in Dermatology Spotlight Event
Published: 2022-04-20 (Crawled : 13:20) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.96%
H: 0.32%
C: -2.54%
innovation
Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting
Published: 2022-03-24 (Crawled : 13:30) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 4.99%
H: 0.26%
C: -4.75%
presentation
Novan, Inc. to Present at Two Upcoming Investor Conferences
Published: 2022-03-14 (Crawled : 13:30) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -11.57%
H: 0.0%
C: 0.0%
conference
EVENING POST GROUP SELLS EPI HEALTH TO NOVAN, INC
Published: 2022-03-11 (Crawled : 23:00) - prnewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
| Email alert
Add to watchlist
health pos group
Novan Acquires EPI Health, a Specialty Dermatology Company
Published: 2022-03-11 (Crawled : 12:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 15.43%
H: 0.0%
C: 0.0%
health derm
Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-22 (Crawled : 12:30) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -7.12%
H: 6.3%
C: -0.55%
financial results report results
Novan to Report Full Year 2021 Financial Results on February 22, 2022
Published: 2022-02-15 (Crawled : 14:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.03%
H: 2.94%
C: 2.21%
financial results report results
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
Published: 2022-01-14 (Crawled : 14:30) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
ces conference presentation
Novan to Participate in the Virtual Investor Roundtable Event
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-10 (Crawled : 11:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: -1.13%
H: 1.52%
C: -0.05%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.9%
H: 2.27%
C: -6.52%
financial results results
Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
covid treatment preclinical covid-19 pre-clinical
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.44%
H: 5.26%
C: 2.7%
Novan to Report Third Quarter 2021 Financial Results on November 10, 2021Company to host conference call and webcast on Wednesday, November 10, 2021, at 8:30 a.m. ET
Published: 2021-11-03 (Crawled : 20:00) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
financial results results conference
Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
Published: 2021-11-03 (Crawled : 14:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
financial results results
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
Published: 2021-11-02 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.7%
H: 1.0%
C: -0.14%
molluscum fda fda acceptance
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.24%
H: 2.39%
C: 0.95%
phase 3
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET –
Published: 2021-09-20 (Crawled : 20:00) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -4.21%
H: 1.59%
C: 0.61%
ford conference
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -4.21%
H: 1.59%
C: 0.61%
conference
Novan Announces Strategic Priorities and Outlines Key Milestones
Published: 2021-09-09 (Crawled : 13:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: 0.17%
H: 0.91%
C: -0.21%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -6.59%
H: 0.0%
C: -4.42%
milestone
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
Published: 2021-09-08 (Crawled : 14:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: 0.19%
H: 0.0%
C: -0.93%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.31%
H: 5.89%
C: 3.56%
health commercialization
Gainers vs Losers
| 47% | 53% |
Top 10 Gainers
TPET | $0.4801 107.75% 16M
|
n/a
WISA 4 | $3.17 81.14% 36M
|
Electronic Technology
PALI | $7.41 78.13% 14M
|
Manufacturing
SPCB | $0.4278 55.0% 17M
|
Electronic Technology
BTTR | $7.61 49.22% 1.8M
|
Manufacturing
PRSO | $1.79 40.95% 25M
|
Manufacturing
DYNT | $0.5203 40.47% 17M
|
Health Technology
JAGX | $0.1668 40.4% 110M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
SNGX | $0.5155 33.52% 3.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.